Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Cerebral Peduncle Angle: An Objective Criterion for Assessing Progressive Supranuclear Palsy Richardson Syndrome.

Fatterpekar GM, Dietrich A, Pantano P, Saba L, Knopp EA, Piattella MC, Raz E.

AJR Am J Roentgenol. 2015 Aug;205(2):386-91. doi: 10.2214/AJR.14.12724.

PMID:
26204292
2.

Somatic ATP2A2 mutation in a case of papular acantholytic dyskeratosis: mosaic Darier disease.

Knopp EA, Saraceni C, Moss J, McNiff JM, Choate KA.

J Cutan Pathol. 2015 Nov;42(11):853-7. doi: 10.1111/cup.12551. Epub 2015 Aug 12.

3.

Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous system.

Gutierrez JE, Rosenberg M, Duhaney M, Simon JA, Brueggenwerth G, Agris JM, Knopp EA.

J Magn Reson Imaging. 2015 Mar;41(3):788-96. doi: 10.1002/jmri.24583. Epub 2014 Feb 27.

PMID:
24578298
4.
5.

Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain.

Jensen JH, Szulc K, Hu C, Ramani A, Lu H, Xuan L, Falangola MF, Chandra R, Knopp EA, Schenck J, Zimmerman EA, Helpern JA.

Magn Reson Med. 2009 Feb;61(2):481-5. doi: 10.1002/mrm.21823.

6.

Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma.

Narayana A, Golfinos JG, Fischer I, Raza S, Kelly P, Parker E, Knopp EA, Medabalmi P, Zagzag D, Eagan P, Gruber ML.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):383-9. doi: 10.1016/j.ijrobp.2008.05.062.

PMID:
18793954
7.

High-grade glioma before and after treatment with radiation and Avastin: initial observations.

Fischer I, Cunliffe CH, Bollo RJ, Raza S, Monoky D, Chiriboga L, Parker EC, Golfinos JG, Kelly PJ, Knopp EA, Gruber ML, Zagzag D, Narayana A.

Neuro Oncol. 2008 Oct;10(5):700-8. doi: 10.1215/15228517-2008-042. Epub 2008 Aug 12.

8.

Nephrogenic systemic fibrosis: early recognition and treatment.

Knopp EA, Cowper SE.

Semin Dial. 2008 Mar-Apr;21(2):123-8. doi: 10.1111/j.1525-139X.2007.00399.x. Epub 2008 Jan 23. Review.

PMID:
18226008
9.

Brain MRI: tumor evaluation.

Young RJ, Knopp EA.

J Magn Reson Imaging. 2006 Oct;24(4):709-24. Review.

PMID:
16958058
10.

Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery.

Truong MT, St Clair EG, Donahue BR, Rush SC, Miller DC, Formenti SC, Knopp EA, Han K, Golfinos JG.

Neurosurgery. 2006 Jul;59(1):86-97; discussion 86-97.

PMID:
16823304
11.

Comparing real-world advantages for the clinical neuroradiologist between a high field (3 T), a phased array (1.5 T) vs. a single-channel 1.5-T MR system.

Orbach DB, Wu C, Law M, Babb JS, Lee R, Padua A, Knopp EA.

J Magn Reson Imaging. 2006 Jul;24(1):16-24.

PMID:
16767701
12.

Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.

Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA, Johnson G.

Radiology. 2006 Feb;238(2):658-67. Epub 2006 Jan 5.

PMID:
16396838
13.

Neuroimaging of metastatic brain disease.

Young RJ, Sills AK, Brem S, Knopp EA.

Neurosurgery. 2005 Nov;57(5 Suppl):S10-23; discusssion S1-4. Review.

PMID:
16237282
14.

Brain compression without global neuronal loss in meningiomas: whole-brain proton MR spectroscopy report of 2 cases.

Cohen BA, Knopp EA, Rusinek H, Liu S, Gonen O.

AJNR Am J Neuroradiol. 2005 Oct;26(9):2178-82.

15.

Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy.

Cohen BA, Knopp EA, Rusinek H, Babb JS, Zagzag D, Gonen O.

AJNR Am J Neuroradiol. 2005 Oct;26(9):2170-7.

16.

Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.

O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):785-90. Epub 2005 Feb 3.

PMID:
15692094
17.

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL.

J Clin Oncol. 2004 Dec 15;22(24):4881-7. Erratum in: J Clin Oncol. 2005 Apr 20;23(12):2877.

PMID:
15611503
18.

Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.

Law M, Hamburger M, Johnson G, Inglese M, Londono A, Golfinos J, Zagzag D, Knopp EA.

Technol Cancer Res Treat. 2004 Dec;3(6):557-65. Review.

PMID:
15560713
19.

Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosis.

O'Brien KD, Lewis K, Fischer JW, Johnson P, Hwang JY, Knopp EA, Kinsella MG, Barrett PH, Chait A, Wight TN.

Atherosclerosis. 2004 Nov;177(1):29-35.

PMID:
15488862
20.

Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in ganglioglioma.

Law M, Meltzer DE, Wetzel SG, Yang S, Knopp EA, Golfinos J, Johnson G.

Magn Reson Imaging. 2004 Jun;22(5):599-606.

PMID:
15172052
21.

Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G.

AJNR Am J Neuroradiol. 2004 May;25(5):746-55.

22.

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D.

AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98.

23.

Importance of MR technique for stereotactic radiosurgery.

Donahue BR, Goldberg JD, Golfinos JG, Knopp EA, Comiskey J, Rush SC, Han K, Mukhi V, Cooper JS.

Neuro Oncol. 2003 Oct;5(4):268-74.

24.

Estrogen therapies, lipids, and the heart disease prevention controversy.

Knopp RH, Aikawa K, Knopp EA.

Curr Cardiol Rep. 2003 Nov;5(6):477-82. Review.

PMID:
14558990
25.

Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas.

Yang S, Law M, Zagzag D, Wu HH, Cha S, Golfinos JG, Knopp EA, Johnson G.

AJNR Am J Neuroradiol. 2003 Sep;24(8):1554-9.

26.

Dynamic contrast enhanced perfusion MRI in mycosis fungoides.

Law M, Teicher N, Zagzag D, Knopp EA.

J Magn Reson Imaging. 2003 Sep;18(3):364-7.

PMID:
12938134
27.

Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas.

Kuo DJ, Weiner HL, Wisoff J, Miller DC, Knopp EA, Finlay JL.

J Pediatr Hematol Oncol. 2003 May;25(5):372-8.

PMID:
12759623
28.

Proton MR spectroscopy of tumefactive demyelinating lesions.

Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D.

AJNR Am J Neuroradiol. 2002 Sep;23(8):1378-86.

29.

Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examination.

Wetzel SG, Johnson G, Tan AG, Cha S, Knopp EA, Lee VS, Thomasson D, Rofsky NM.

AJNR Am J Neuroradiol. 2002 Jun-Jul;23(6):995-1002.

30.

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D.

Radiology. 2002 Apr;223(1):11-29. Review.

PMID:
11930044
31.

High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.

Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW.

Radiology. 2002 Mar;222(3):715-21.

PMID:
11867790
32.

Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.

Cha S, Pierce S, Knopp EA, Johnson G, Yang C, Ton A, Litt AW, Zagzag D.

AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1109-16.

33.

Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.

Cha S, Knopp EA, Johnson G, Litt A, Glass J, Gruber ML, Lu S, Zagzag D.

AJNR Am J Neuroradiol. 2000 May;21(5):881-90.

34.
35.

Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.

Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II.

Radiology. 1999 Jun;211(3):791-8.

PMID:
10352608
36.

Murine phospholipid hydroperoxide glutathione peroxidase: cDNA sequence, tissue expression, and mapping.

Knopp EA, Arndt TL, Eng KL, Caldwell M, LeBoeuf RC, Deeb SS, O'Brien KD.

Mamm Genome. 1999 Jun;10(6):601-5.

PMID:
10341094
37.

Mycosis fungoides metastasizing to the brain parenchyma: case report.

Zonenshayn M, Sharma S, Hymes K, Knopp EA, Golfinos JG, Zagzag D.

Neurosurgery. 1998 Apr;42(4):933-7.

PMID:
9574661
38.

Contrast-enhancing progressive multifocal leukoencephalopathy: radiological and pathological correlations: case report.

Woo HH, Rezai AR, Knopp EA, Weiner HL, Miller DC, Kelly PJ.

Neurosurgery. 1996 Nov;39(5):1031-4; discussion 1034-5.

PMID:
8905761
39.

The role of magnetic resonance angiography in the assessment of intracranial vascular disease.

Knopp EA.

Neuroimaging Clin N Am. 1996 Aug;6(3):769-80. Review.

PMID:
8873104
40.

Water excitation MPRAGE MRI of VII and VIII cranial nerves.

Litt AW, Licata P, Knopp EA, Thomasson DM.

J Comput Assist Tomogr. 1996 Mar-Apr;20(2):194-200.

PMID:
8606222
41.

Venous disease and tumors.

Knopp EA.

Magn Reson Imaging Clin N Am. 1995 Aug;3(3):509-28. Review.

PMID:
7584254
42.

MP-RAGE subtraction venography: a new technique.

Stevenson J, Knopp EA, Litt AW.

J Magn Reson Imaging. 1995 Mar-Apr;5(2):239-41.

PMID:
7766987
43.

Primary lymphoma of the cauda equina: myelographic, CT myelographic, and MR appearance.

Knopp EA, Chynn KY, Hughes J.

AJNR Am J Neuroradiol. 1994 Jun;15(6):1187-9.

PMID:
8073994
44.

Spontaneous expulsive choroidal hemorrhage: CT findings.

Knopp EA, Chynn KY.

AJNR Am J Neuroradiol. 1990 Nov-Dec;11(6):1208-9. No abstract available.

PMID:
2124061
45.

Preservation of myocardial ATP during cardioplegia: comparison of techniques.

Catinella FP, Knopp EA, Cunningham JN Jr.

J Cardiovasc Surg (Torino). 1984 Jul-Aug;25(4):296-303.

PMID:
6480681
46.

Experimental and clinical assessment of the adequacy of partial bypass in maintenance of spinal cord blood flow during operations on the thoracic aorta.

Laschinger JC, Cunningham JN Jr, Nathan IM, Knopp EA, Cooper MM, Spencer FC.

Ann Thorac Surg. 1983 Oct;36(4):417-26.

PMID:
6625737
47.

'Pulsatile' left atrial-femoral artery bypass. A new method of preventing extension of myocardial infarction.

Laschinger JC, Cunningham JN Jr, Catinella FP, Knopp EA, Glassman E, Spencer FC.

Arch Surg. 1983 Aug;118(8):965-9.

PMID:
6870527
48.

Preservation of myocardial ATP. Comparison of blood vs crystalloid cardioplegia.

Catinella FP, Cunningham JN Jr, Knopp EA, Laschinger JC, Spencer FC.

Chest. 1983 Apr;83(4):650-4.

PMID:
6831955
49.

Myocardial protection with cold blood potassium cardioplegia during prolonged aortic cross-clamping. Laboratory evaluation.

Catinella FP, Cunningham JN Jr, Knopp EA, Srungaram RK, Nathan IM.

N Y State J Med. 1983 Apr;83(5):721-6. No abstract available.

PMID:
6575278
50.

Detection and prevention of intraoperative spinal cord ischemia after cross-clamping of the thoracic aorta: use of somatosensory evoked potentials.

Laschinger JC, Cunningham JN Jr, Catinella FP, Nathan IM, Knopp EA, Spencer FC.

Surgery. 1982 Dec;92(6):1109-17. No abstract available.

PMID:
7147189

Supplemental Content

Loading ...
Support Center